As of 2026-01-19, the Relative Valuation of Organogenesis Holdings Inc (ORGO) is 0.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.79 USD, the upside of Organogenesis Holdings Inc based on Relative Valuation is -93.2%.
The range of the Relative Valuation is 0.13 - 0.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 20.8x | 18.2x |
| Forward P/E multiples | 17.3x - 27.1x | 21.1x |
| Fair Price | 0.13 - 0.48 | 0.26 |
| Upside | -96.5% - -87.4% | -93.2% |
| Date | P/E |
| 2026-01-16 | 478.60 |
| 2026-01-15 | 501.33 |
| 2026-01-14 | 488.70 |
| 2026-01-13 | 515.22 |
| 2026-01-12 | 534.16 |
| 2026-01-09 | 531.63 |
| 2026-01-08 | 531.63 |
| 2026-01-07 | 543.00 |
| 2026-01-06 | 550.57 |
| 2026-01-05 | 556.89 |
| 2026-01-02 | 585.30 |
| 2025-12-31 | 654.12 |
| 2025-12-30 | 654.12 |
| 2025-12-29 | 657.91 |
| 2025-12-26 | 666.12 |
| 2025-12-24 | 741.26 |
| 2025-12-23 | 726.10 |
| 2025-12-22 | 721.05 |
| 2025-12-19 | 707.16 |
| 2025-12-18 | 728.63 |
| 2025-12-17 | 665.49 |
| 2025-12-16 | 652.86 |
| 2025-12-15 | 609.93 |
| 2025-12-12 | 608.66 |
| 2025-12-11 | 602.35 |
| 2025-12-10 | 597.30 |
| 2025-12-09 | 587.20 |
| 2025-12-08 | 588.46 |
| 2025-12-05 | 598.56 |
| 2025-12-04 | 621.29 |
| 2025-12-03 | 630.13 |
| 2025-12-02 | 633.92 |
| 2025-12-01 | 641.50 |
| 2025-11-28 | 654.12 |
| 2025-11-26 | 684.43 |
| 2025-11-25 | 666.75 |
| 2025-11-24 | 680.64 |
| 2025-11-21 | 705.90 |
| 2025-11-20 | 646.55 |
| 2025-11-19 | 647.81 |
| 2025-11-18 | 697.06 |
| 2025-11-17 | 756.41 |
| 2025-11-14 | 770.30 |
| 2025-11-13 | 784.19 |
| 2025-11-12 | 818.29 |
| 2025-11-11 | 820.81 |
| 2025-11-10 | 825.86 |
| 2025-11-07 | 710.95 |
| 2025-11-06 | 491.22 |
| 2025-11-05 | 501.33 |